GlassScriptPhysician profile
John S Jaggers
NPI 1568403178
$14,204.97
in general payments reported to CMS, 2019-2025
54 companies · $2,668 in 2025
The $2,668 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,196 · 2020: $1,319 · 2021: $1,682 · 2022: $1,847 · 2023: $1,998 · 2024: $2,495 · 2025: $2,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,122 · Education: $38.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,122.41 |
| Education | $38.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,451.85 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,801.05 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Actelion Pharmaceuticals US, INC. | $1,451.24 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols USA, LLC | $1,189.98 | 2019-2025 | Prolastin-C Liquid |
| Insmed, INC. | $856.24 | 2022-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $587.41 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Sunovion Pharmaceuticals INC. | $490.45 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $487.86 | 2019-2023 | |
| Genzyme Corporation | $452.68 | 2020-2025 | |
| Mylan Specialty L.P. | $410.37 | 2019-2024 | Yupelri |
| Baxter Healthcare | $366.87 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Inspire Medical Systems, INC. | $355.27 | 2023-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $303.18 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $295.34 | 2021-2025 | Tyvaso, Tyvaso |
| Pfizer INC. | $246.46 | 2022-2024 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $234.10 | 2025 | Ohtuvayre |
| Astellas Pharma US INC | $219.00 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $204.47 | 2019-2025 | Winrevair, Zerbaxa, Keytruda |
| Electromed, INC. | $198.58 | 2022-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $159.96 | 2022-2025 | Glassia |
| Axsome Therapeutics, INC. | $140.95 | 2023-2024 | Sunosi |
| Mallinckrodt Hospital Products INC. | $128.86 | 2020-2025 | Acthar |
| Genentech USA, INC. | $106.33 | 2019-2020 | |
| Viatris Specialty LLC | $103.31 | 2025 | Yupelri |
| La Jolla Pharmaceutical Company | $102.64 | 2024-2025 | Xacduro, Giapreza |
| Pulmonx Corporation | $68.96 | 2022-2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Advanced Respiratory, INC | $65.00 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $62.30 | 2019-2023 | |
| Philips North America LLC | $61.86 | 2019-2022 | |
| Lilly USA, LLC | $56.61 | 2025 | Zepbound, Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $48.75 | 2019-2022 | |
| Resmed Corp | $47.95 | 2023 | |
| Inogen, INC. | $31.22 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Teva Pharmaceuticals USA, INC. | $29.80 | 2021 | |
| Caris Mpi, INC. | $29.20 | 2025 | Mi Cancer Seek |
| Arbor Pharmaceuticals, INC. | $28.50 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $25.18 | 2023 | Lumryz |
| Zoll Respicardia, INC. | $24.73 | 2022 | |
| Vifor Pharma, INC. | $24.57 | 2024 | Zemaira |
| Gilead Sciences, INC. | $21.81 | 2022 | |
| Harmony Biosciences LLC | $21.26 | 2022 | |
| Portola Pharmaceuticals, LLC | $20.51 | 2019 | |
| Csl Behring | $19.86 | 2021 | |
| Mallinckrodt Enterprises LLC | $19.24 | 2019 | |
| Abbvie INC. | $18.86 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.49 | 2023 | Quviviq |
| Ambu INC. | $17.37 | 2023 | |
| Amgen INC. | $16.34 | 2025 | Tavneos |
| Fisher & Paykel Healthcare INC | $16.01 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.55 | 2023 | Nuzyra |
| Allergan, INC. | $13.86 | 2019 | |
| Breas Medical, INC. | $13.40 | 2025 | Vivo 45 Ls |
| Biogen, INC. | $12.27 | 2022 | |
| Circassia INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jaggers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.